SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-07-001946
Filing Date
2007-03-30
Accepted
2007-03-30 09:48:24
Documents
3
Period of Report
2007-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LA JOLLA PHARMACEUTICALS COMPANY b646218ke8vk.htm 8-K 15031
2 EX-1.1 UNDERWRITING AGREEMENT, DATED MARCH 29, 2007 b646218kexv1w1.txt EX-1.1 99795
3 EX-99.1 PRESS RELEASE, DATED MARCH 29, 2007 b646218kexv99w1.htm EX-99.1 5037
  Complete submission text file 0000950135-07-001946.txt   121418
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 07729678
SIC: 2836 Biological Products, (No Diagnostic Substances)